Greenwich LifeSciences, Inc.
GLSI
$8.41
$0.415.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 21.39% | -21.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.18% | 23.27% | |||
| Operating Income | -3.18% | -23.27% | |||
| Income Before Tax | -3.14% | -23.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.14% | -23.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.14% | -23.54% | |||
| EBIT | -3.18% | -23.27% | |||
| EBITDA | -3.20% | -23.27% | |||
| EPS Basic | -1.13% | -21.67% | |||
| Normalized Basic EPS | -1.06% | -21.73% | |||
| EPS Diluted | -1.13% | -21.67% | |||
| Normalized Diluted EPS | -1.06% | -21.73% | |||
| Average Basic Shares Outstanding | 2.02% | 1.51% | |||
| Average Diluted Shares Outstanding | 2.02% | 1.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||